Le Lézard
Classified in: Health
Subject: CALENDAR OF EVENTS

The Dream Machine: When Fiction Exceeds Reality


MONTREAL, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Attend the launch of The Dream Machine, a book by Candace Amarante, beautifully illustrated by Dave Reed! The Shriners Hospital for Children - Canada, in the company of Maria Farella, whose philanthropic successes and commitment to the mental health of young people are well known (e.g. President of the fundraising event Notte in Bianco since 2008), will be celebrating the release of this excellent tool from its Nursing Research Department at a press conference. This magical children's book opens up new horizons for children with rare or chronic illnesses, and provides them with tools and hope to manage their pain better, whether physical or mental.

Wednesday, September 27, 2023
At 10:00 AM
Shriners Hospitals for Children? Canada
Rooms 2.28 & 2.30, 2nd Floor
1003, Décarie Boulevard., Montréal (Québec) H4A 0A9

Parking is free for our guests. Enter the underground parking lot to level P3A - zone 100.

Author Candace Amarante, Illustrator Dave Reed, Principal Investigator Argerie Tsimicalis, Ph.D., Drs. Reggie Hamdy and Frank Rauch, co-directors of the Osteogenesis Imperfecta (or brittle bone disease) program, and our patient, Carter, will be on hand to tell the fantastic story of how this book came to be.

Information
Laure Moureaux, Communications Advisor, Shriners Hospitals for Children ? Canada,
Cell: 514-207-2267, [email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/53fa6a0d-acb0-48fc-b812-77600ad4e2fe



These press releases may also interest you

at 17:25
Talphera, Inc. , ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, today announced that the Board of Directors of Talphera has granted...

at 16:56
A paper published in the June edition of the Journal Diabetes demonstrates that C-peptide, a biomarker that indicates the production of insulin, is a validated surrogate endpoint, or predictor of clinical benefit, for clinical trials of...

at 16:28
?Patients Treated with ARIKAYCE Plus Macrolide-Based Background Regimen Had Meaningfully Greater Improvements in Respiratory Symptoms vs. Macrolide-Based Background Regimen Alone, As Measured By the QOL-B Respiratory Domain Instrument? ?QOL-B...

at 16:20
Jarrard Inc., a leading national healthcare strategic communications consultancy, has expanded by 10 percent, adding seven new professionals to address the increasing demand for its healthcare advisory services. The team now includes 81 full-time...

at 16:10
Pulse Biosciences, Inc. ("Pulse" or the "Company"), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablationtm (nsPFAtm) technology, today announced that the Company's Board of Directors has determined a new record...

at 16:10
Contineum Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies that target biological pathways associated with specific clinical impairments for the treatment of...



News published on and distributed by: